Results 181 to 190 of about 24,103,638 (294)
How the First Medical Imaging Cancer Atlas EUCAIM Was Populated: The Experience of a Reference Hospital. [PDF]
Penadés Blasco A +8 more
europepmc +1 more source
Student perspectives on AI‐supported formative assessment in pharmacology
Abstract Aims High‐quality feedback is crucial for helping medical students understand and apply core concepts of pharmacology, yet personalized feedback is resource‐intensive to produce. Artificial intelligence (AI) offers a potential solution, but little is known about students' perspectives on AI‐generated feedback.
Jon Andsnes Berg +6 more
wiley +1 more source
Challenges of identification and anonymity in time-continuous data from medical environments. [PDF]
Hammer F, Strufe T.
europepmc +1 more source
Aims To determine the prevalence of non‐adherence to antihypertensive medicines and to identify demographic and behavioral factors associated with non‐adherence in subjects enrolled in the May Measurement Month (MMM) 2023, as part of the permanent public health action Hunting the silent killer.
Valerija Bralić Lang +12 more
wiley +1 more source
Enhanced secure storage and data privacy management system for big data based on multilayer model. [PDF]
Ting T, Li M.
europepmc +1 more source
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale +5 more
wiley +1 more source
Abstract Aims Chemical Adherence Testing (CAT) is gaining prominence as a reliable and valid clinical method to detect whether antihypertensive agents are being taken as prescribed. This study aimed to explore clinicians' attitudes and perspectives on the clinical use of CAT.
Roshan Shahab +2 more
wiley +1 more source
SynthCraft: An AI partner for synthetic data generation to support data access and augmentation in healthcare. [PDF]
Callender T +5 more
europepmc +1 more source
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola +5 more
wiley +1 more source
Evaluating the accuracy of automated and semi-automated anonymization tools for unstructured health records. [PDF]
Alrazihi LA, Biswas S, George J.
europepmc +1 more source

